Alopecia Treatment Market - By Treatment Type: Topical Treatment, Oral Treatment, Injectable Treatment, Hair Transplantation. By End-user: Hospitals, Clinics, Homecare Settings. By Application: Male Alopecia, Female Alopecia. By Region: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa.
The global Alopecia Treatment Market was valued at 8.3 billion in 2023 and is projected to reach 18.6 billion by 2031, growing at a CAGR of 10.4%. The market is driven by the rising prevalence of hair loss disorders, advancements in regenerative medicine, and increasing demand for minimally invasive solutions.
2024 Market Breakthroughs
Market Drivers
1. Rising Prevalence
2. Treatment Innovations
3. Aesthetic Demand
Competitive Landscape
|
Company |
Market Share |
Flagship Product |
Strategic Edge |
|
Eli Lilly |
28% |
Olumiant® (JAK inhibitor) |
First systemic AA treatment |
|
Pfizer |
XX% |
Litfulo® (JAK3/TEC) |
Pediatric indication |
|
Restoration Robotics |
XX% |
ARTAS iX® |
AI-powered FUE |
Emerging Disruptors:
Market Segmentation
Recent Developments (2024)
August 2024: Stemson’s iPSC hair follicles enter clinical trials
Global Alopecia Treatment Market Report
Need help?
Chat with our team in a minute.